Focus on MicroRNAs as Biomarker in Pediatric Diseases

Author(s): Giuseppe Lassandro, Loredana Ciaccia, Anna Amoruso, Valentina Palladino, Viviana V. Palmieri, Paola Giordano*

Journal Name: Current Pharmaceutical Design

Volume 27 , Issue 6 , 2021


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: MiRNAs are a class of small non-coding RNAs that are involved in the post-transcriptional regulation of gene expression. MiRNAs are considered a class of epigenetic biomarkers. These biomarkers can investigate disease at different stages: diagnosis, therapy or clinical follow-up.

Objective: The aim of this paper is to highlight the innovative use of miRNAs in several childhood diseases.

Methods: We conducted a literature review to search the usage of miRNAs in pediatric clinical routine or experimental trials.

Results: We found a possible key role of miRNAs in different pediatric illnesses (metabolic alterations, coagulation defects, cancer).

Conclusion: The modest literature production denotes that further investigation is needed to assess and validate the promising role of miRNAs as non-invasive biomarkers in pediatric disorders.

Keywords: MicroRNAs, pediatrics, children, biomarker, hemophilia, cancer, autism, metabolic syndrome.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 27
ISSUE: 6
Year: 2021
Published on: 14 March, 2021
Page: [826 - 832]
Pages: 7
DOI: 10.2174/1381612826666201021125512
Price: $65

Article Metrics

PDF: 88